Filing Details

Accession Number:
0001694665-23-000053
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-10 21:31:52
Reporting Period:
2023-05-08
Accepted Time:
2023-05-10 21:31:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1694665 Evelo Biosciences Inc. EVLO Pharmaceutical Preparations (2834) 465594527
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1738885 Mark Bodmer C/O Evelo Biosciences, Inc.
620 Memorial Drive
Cambridge MA 02139
Cso, President Of R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-05-08 68,014 $0.13 285,128 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction entered into by the Reporting Person on December 16, 2022, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
  2. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices within the range of $0.12 to $0.13, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.